Etoposide Injection
Product Images NDC 0143-9512
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 0143-9512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vial Label For Etoposide Injection, Usp 100 mg/5 mL (Etoposide Injection Usp 2)
Vial Label For Etoposide Injection, Usp 500 mg/25 mL (Etoposide Injection Usp 3)
NDC 0143-9511-01 is a multiple dose vial of Etoposide Injection, USP used for intravenous infusion. Each mL of the medication contains 20 mg etoposide and other ingredients such as citric acid, benzyl alcohol, poly sorbate 80, polyethylene glycol 300 and alcohol. It is important to dilute the medication before use. The details of the recommended dosage can be found in the package insert. The medication should be stored at controlled room temperature. This product is distributed by West-Ward Pharmaceuticals.*
Vial Label For Etoposide Injection, Usp 1 G/50 mL (Etoposide Injection Usp 4)
Representative Carton Serialization Image (Etoposide Injection Usp 5)
Representative Carton Serialization Image (Etoposide Injection Usp 6)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.